LINE

Text:AAAPrint
Sci-tech

Research uncovers breakthrough with breast cancer drug: study

1
2017-03-14 13:49:01Xinhua Gu Liping ECNS App Download

New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency, it was revealed on Tuesday.

When there's a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

"The BRCA1 and BRCA2 genes are guardians that look after DNA in our body," study researcher Dr. Peter Simpson told Xinhua.

"These are really critical genes in every cell of our body and they go through and repair DNA when it gets damaged."

By using a computer program to map the Genome sequencing of mutations in 560 breast cancers, the University of Queensland in Australia, along with the Sanger Institute in Britain, were able to look at different patterns of mutation and understand how a tumour had arisen.

"Results showed that almost 22 percent of breast tumours had a genetic signature reflecting a BRCA deficiency, even though the patient had not always inherited a mutation in one of the two genes," Simpson said.

In clinical trials at the moment, PARP inhibitor drugs can act to restore these BRCA1 or BRCA2 genes.

"It's very significant, it's building a really big body of evidence to suggest that in the future we can sequence a patient's tumour, we can understand the mutation and say whether the patient will respond better to chemotherapy of the PARP drug," he said.

"In the future we can see this kind of test becoming a kind of diagnostic that will determine what type of therapy a patient will have, this pattern of mutation will be a useful bio-marker."

 

  

Related news

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.